Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BISENA BULICA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1093152019
CMS profile
94283
Location
DETROIT, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$180,069.26

335 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Neurocrine Biosciences, Inc. $124,719.23 198
Teva Pharmaceuticals USA, Inc. $44,061.34 71
MDD US Operations, LLC $4,104.01 11
ACADIA Pharmaceuticals Inc $2,140.92 5
Medtronic, Inc. $1,732.91 18
Roche Products Limited $1,683.90 3
AbbVie Inc. $493.97 6
Supernus Pharmaceuticals, Inc. $190.30 3
Abbott Laboratories $166.59 1
Boston Scientific Corporation $150.19 1
Acorda Therapeutics, Inc $146.77 10
Eisai Inc. $145.52 2
UCB, Inc. $122.82 1
Kyowa Kirin, Inc. $122.46 3
Genentech, Inc. $88.33 2

Page 2 of 7; records 51–100 of 335 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BISENA BULICA

NPI 1093152019 · CMS profile ID 94283

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

DETROIT, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 7; records 51–100 of 335 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1093152019?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BISENA BULICA, NPI 1093152019, CMS profile ID 94283. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 7; records 51–100 of 335 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1093152019?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). BISENA BULICA, NPI 1093152019, CMS profile ID 94283. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 7; records 51–100 of 335 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1093152019?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
BISENA BULICA, NPI 1093152019, CMS profile ID 94283, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 7; records 51–100 of 335 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1093152019?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

335 matching records · $180,069.26 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 335 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 335.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Acorda Therapeutics, Inc $13.8011/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1005342291 CMS
Neurocrine Biosciences, Inc. $1,800.0011/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988949 CMS
Roche Products Limited $185.4211/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040313129 CMS
Roche Products Limited $764.8411/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040313135 CMS
Roche Products Limited $733.6411/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040313141 CMS
Neurocrine Biosciences, Inc. $2.9611/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988739 CMS
Teva Pharmaceuticals USA, Inc. $77.7511/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056716947 CMS
AbbVie Inc. $345.0010/31/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996329031 CMS
Teva Pharmaceuticals USA, Inc. $134.2510/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056716945 CMS
Teva Pharmaceuticals USA, Inc. $70.7410/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056717169 CMS
Teva Pharmaceuticals USA, Inc. $101.2510/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056717171 CMS
Teva Pharmaceuticals USA, Inc. $127.3810/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056717173 CMS
Teva Pharmaceuticals USA, Inc. $226.6210/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056717175 CMS
Teva Pharmaceuticals USA, Inc. $933.7110/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056717177 CMS
Teva Pharmaceuticals USA, Inc. $4,420.0010/26/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056717179 CMS
Neurocrine Biosciences, Inc. $3,600.0010/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989507 CMS
Neurocrine Biosciences, Inc. $4.5010/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989511 CMS
Neurocrine Biosciences, Inc. $55.9110/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989519 CMS
Neurocrine Biosciences, Inc. $257.5910/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989523 CMS
Neurocrine Biosciences, Inc. $278.1310/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989529 CMS
Neurocrine Biosciences, Inc. $5.0010/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989533 CMS
AbbVie Inc. $3.9710/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996329029 CMS
Neurocrine Biosciences, Inc. $68.1210/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988877 CMS
Neurocrine Biosciences, Inc. $56.0010/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988885 CMS
Neurocrine Biosciences, Inc. $7.0010/23/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988889 CMS
Neurocrine Biosciences, Inc. $55.2010/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988901 CMS
Neurocrine Biosciences, Inc. $8.6110/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988732 CMS
Neurocrine Biosciences, Inc. $3,150.0010/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988873 CMS
Neurocrine Biosciences, Inc. $457.8610/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989385 CMS
Neurocrine Biosciences, Inc. $81.5310/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989539 CMS
Neurocrine Biosciences, Inc. $760.7010/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989545 CMS
Neurocrine Biosciences, Inc. $3,150.0010/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989605 CMS
Neurocrine Biosciences, Inc. $173.7810/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988853 CMS
Neurocrine Biosciences, Inc. $106.8310/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988861 CMS
Neurocrine Biosciences, Inc. $4,275.0010/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988865 CMS
Neurocrine Biosciences, Inc. $303.0410/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989369 CMS
Neurocrine Biosciences, Inc. $10.0010/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989377 CMS
Neurocrine Biosciences, Inc. $886.3710/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989391 CMS
Neurocrine Biosciences, Inc. $278.7910/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989395 CMS
Neurocrine Biosciences, Inc. $527.8010/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051989037 CMS
Acorda Therapeutics, Inc $10.3810/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1005342293 CMS
Teva Pharmaceuticals USA, Inc. $6.0610/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056716943 CMS
Neurocrine Biosciences, Inc. $4,837.5010/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051988897 CMS
Teva Pharmaceuticals USA, Inc. $64.8610/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056716941 CMS
Teva Pharmaceuticals USA, Inc. $14.4510/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056717163 CMS
Teva Pharmaceuticals USA, Inc. $43.2310/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056717165 CMS
Teva Pharmaceuticals USA, Inc. $2,600.0010/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056717167 CMS
Acorda Therapeutics, Inc $14.3310/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1005342295 CMS
ACADIA Pharmaceuticals Inc $1.9710/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053120651 CMS
Genentech, Inc. $43.8110/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040313123 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,651.20 66
PY2020 $2,133.26 90
PY2021 $54,849.62 148
PY2022 $181,961.06 296
PY2023 $180,069.26 335
PY2024 $204,849.09 414
PY2025 $271,834.58 519

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $439,137.15 17
PY2024 Principal investigator $77,947.16 3
PY2021 Principal investigator $26,379.88 20

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

17 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Roche TCRC, Inc. $27,348.00 12/24/2025 Covered Recipient Teaching Hospital
Henry Ford West Bloomfield Hospital
Phase II study in early stage Parkinson s Disease Patients No dispute reported 06/30/2026 1211545118
Principal investigator 1 Genentech, Inc. $46,969.00 12/03/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
Phase II dose finding study in prodromal early manifest HD individuals No dispute reported 06/30/2026 1211544902
Principal investigator 1 Genentech, Inc. $227.05 11/17/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
Phase II dose finding study in prodromal early manifest HD individuals No dispute reported 06/30/2026 1211544889
Principal investigator 1 Roche TCRC, Inc. $8,841.60 10/14/2025 Covered Recipient Teaching Hospital
Henry Ford West Bloomfield Hospital
Phase II study in early stage Parkinson s Disease Patients No dispute reported 06/30/2026 1211545114
Principal investigator 1 Roche TCRC, Inc. $3,315.60 09/11/2025 Covered Recipient Teaching Hospital
Henry Ford West Bloomfield Hospital
Phase II study in early stage Parkinson s Disease Patients No dispute reported 06/30/2026 1211545105
Principal investigator 1 Roche TCRC, Inc. $5,526.00 08/14/2025 Covered Recipient Teaching Hospital
Henry Ford West Bloomfield Hospital
Phase II study in early stage Parkinson s Disease Patients No dispute reported 06/30/2026 1211545111
Principal investigator 1 Genentech, Inc. $512.00 06/25/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
Phase II dose finding study in prodromal early manifest HD individuals No dispute reported 06/30/2026 1211544791
Principal investigator 1 Genentech, Inc. $166,346.00 06/24/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
A Phase 2b efficacy safety trial of Prasinezumab in patients with early Parkinson s Disease No dispute reported 06/30/2026 1211544789
Principal investigator 1 Roche TCRC, Inc. $15,766.20 06/13/2025 Covered Recipient Teaching Hospital
Henry Ford West Bloomfield Hospital
Phase II study in early stage Parkinson s Disease Patients No dispute reported 06/30/2026 1211545102
Principal investigator 1 Genentech, Inc. $14,719.00 06/02/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
Phase II dose finding study in prodromal early manifest HD individuals No dispute reported 06/30/2026 1211544795
Principal investigator 1 Genentech, Inc. $105.00 05/02/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
Phase II dose finding study in prodromal early manifest HD individuals No dispute reported 06/30/2026 1211544822
Principal investigator 1 Genentech, Inc. $61,242.00 04/29/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
Phase II dose finding study in prodromal early manifest HD individuals No dispute reported 06/30/2026 1211544838
Principal investigator 1 Genentech, Inc. $1,071.90 03/20/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
Phase II dose finding study in prodromal early manifest HD individuals No dispute reported 06/30/2026 1211544826
Principal investigator 1 Roche TCRC, Inc. $22,564.80 01/16/2025 Covered Recipient Teaching Hospital
Henry Ford West Bloomfield Hospital
Phase II study in early stage Parkinson s Disease Patients No dispute reported 06/30/2026 1211545099
Principal investigator 1 Genentech, Inc. $56,375.00 01/15/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
Phase II dose finding study in prodromal early manifest HD individuals No dispute reported 06/30/2026 1211544812
Principal investigator 1 Genentech, Inc. $90.00 01/14/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
A Phase 2b efficacy safety trial of Prasinezumab in patients with early Parkinson s Disease No dispute reported 06/30/2026 1211544808
Principal investigator 1 Genentech, Inc. $8,118.00 01/09/2025 Covered Recipient Teaching Hospital
Henry Ford Hospital
A Phase 2b efficacy safety trial of Prasinezumab in patients with early Parkinson s Disease No dispute reported 06/30/2026 1211544814